Cramer Rosenthal Mcglynn LLC Bio Techne Corp Transaction History
Cramer Rosenthal Mcglynn LLC
- $1.69 Billion
- Q3 2024
A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 496,815 shares of TECH stock, worth $36.4 Million. This represents 2.34% of its overall portfolio holdings.
Number of Shares
496,815
Previous 373,019
33.19%
Holding current value
$36.4 Million
Previous $26.7 Million
48.54%
% of portfolio
2.34%
Previous 1.64%
Shares
4 transactions
Others Institutions Holding TECH
# of Institutions
602Shares Held
151MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.34 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$690 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$468 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$341 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.87B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...